Entyvio subkutan 108 mg, Injektionslösung in einer Fertigspritze
7680675370016
CH-67537
Injektionslösung
Associated product:
ENTYVIO sous-cutanée 108 mg/0.68ml ser préremp
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Fertigspritze(n)
- Galenic form
- Injektionslösung
- Galenic group
- Injektion/Infusion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
108.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
1.11 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 608.35
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/03/2021
Authorization holder
Takeda Pharma AG
8152 Opfikon
Authorization information
- Swissmedic authorization number
- 67537
- Drug name
- Entyvio subkutan, Injektionslösung in einer Fertigspritze
- Galenic form
- INLFS
- ATC Code
- L04AG05
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 16/10/2020
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.15.0.
- Domain
- Human medicine
Package details
- Description (FR)
- ENTYVIO sous-cutanée 108 mg/0.68ml ser préremp
- Description (DE)
- ENTYVIO subkutan 108 mg/0.68ml Fertigspritze
- Market launch
- 16/10/2020
- Narcotic (BTM)
- No